• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成(+)-和(-)-片螺素的独特结合特性及细胞特性

Distinct binding and cellular properties of synthetic (+)- and (-)-discodermolides.

作者信息

Hung D T, Nerenberg J B, Schreiber S L

机构信息

Howard Hughes Medical Institute, Department of Chemistry, Harvard University, Cambridge, MA 02138, USA.

出版信息

Chem Biol. 1994 Sep;1(1):67-71. doi: 10.1016/1074-5521(94)90042-6.

DOI:10.1016/1074-5521(94)90042-6
PMID:9383372
Abstract

BACKGROUND

Cell permeable ligands of low molecular weight can be used to dissect complex cellular processes. During the past several years this approach has been particularly important in the study of intracellular signal transduction. Discodermolide, a marine natural product, appears to inhibit a signaling pathway in immune cells. The structure of natural discodermolide is known, but its absolute stereochemistry is not. We set out to make both enantiomers and to investigate their biological activity.

RESULTS

Both enantiomers of discodermolide were prepared by total synthesis. Surprisingly, both enantiomers have biological activity, and their effects seem to be distinct in that they arrest cells at different stages of the cell cycle. A specific binding activity was identified for (+)-discodermolide but not for (-)-discodermolide, and the binding of the two enantiomers was not competitive.

CONCLUSIONS

Both enantiomers of discodermolide have antiproliferative activity, but they act by distinct mechanisms and appear to have distinct cellular targets. The natural product is the (+)-enantiomer, which blocks the cell cycle in the G2 or M phase. The (-)-enantiomer blocks cells in S phase. Both may be useful in studies of the regulation of the cell cycle; we have also identified a specific binding activity for (+)-discodermolide, and have provided evidence that it interacts with a functionally relevant receptor.

摘要

背景

低分子量的细胞可渗透配体可用于剖析复杂的细胞过程。在过去几年中,这种方法在细胞内信号转导研究中尤为重要。Discodermolide是一种海洋天然产物,似乎能抑制免疫细胞中的一条信号通路。天然Discodermolide的结构已知,但其绝对立体化学未知。我们着手合成其两种对映体并研究它们的生物活性。

结果

通过全合成制备了Discodermolide的两种对映体。令人惊讶的是,两种对映体均具有生物活性,且它们的作用似乎不同,因为它们能使细胞停滞在细胞周期的不同阶段。已鉴定出(+)-Discodermolide具有特异性结合活性,而(-)-Discodermolide没有,且两种对映体的结合不具有竞争性。

结论

Discodermolide的两种对映体均具有抗增殖活性,但它们的作用机制不同,且似乎具有不同的细胞靶点。天然产物是(+)-对映体,它在G2或M期阻断细胞周期。(-)-对映体在S期阻断细胞。两者在细胞周期调控研究中可能都有用;我们还鉴定出了(+)-Discodermolide的特异性结合活性,并提供了证据表明它与功能相关的受体相互作用。

相似文献

1
Distinct binding and cellular properties of synthetic (+)- and (-)-discodermolides.合成(+)-和(-)-片螺素的独特结合特性及细胞特性
Chem Biol. 1994 Sep;1(1):67-71. doi: 10.1016/1074-5521(94)90042-6.
2
Immunosuppression by discodermolide.由片螺素引起的免疫抑制。
Ann N Y Acad Sci. 1993 Nov 30;696:94-107. doi: 10.1111/j.1749-6632.1993.tb17145.x.
3
(+)-Discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest.(+)-软海绵素以化学计量比与微管蛋白二聚体结合于微管,阻断紫杉醇结合并导致有丝分裂停滞。
Chem Biol. 1996 Apr;3(4):287-93. doi: 10.1016/s1074-5521(96)90108-8.
4
Structure-activity relationship studies of discodermolide and its semisynthetic acetylated analogs on microtubule function and cytotoxicity.Discodermolide及其半合成乙酰化类似物对微管功能和细胞毒性的构效关系研究
Cancer Chemother Pharmacol. 2001 Jul;48(1):29-36. doi: 10.1007/s002800100287.
5
The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies.紫杉醇与(+)-软海绵素之间的关系:合成类似物与模型研究。
Chem Biol. 2001 Sep;8(9):843-55. doi: 10.1016/s1074-5521(01)00055-2.
6
Discodermolide--a new, marine-derived immunosuppressive compound. II. In vivo studies.软海绵素B——一种新型的、源自海洋的免疫抑制化合物。II. 体内研究。
Transplantation. 1991 Oct;52(4):656-61. doi: 10.1097/00007890-199110000-00015.
7
Discodermolide--a new, marine-derived immunosuppressive compound. I. In vitro studies.Discodermolide——一种新的、源自海洋的免疫抑制化合物。I. 体外研究。
Transplantation. 1991 Oct;52(4):650-6. doi: 10.1097/00007890-199110000-00014.
8
Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.Discodermolide与紫杉醇协同抑制非小细胞肺癌细胞中的微管动力学
Cancer Res. 2004 Jul 15;64(14):4957-64. doi: 10.1158/0008-5472.CAN-04-0693.
9
Simplified discodermolide analogues: synthesis and biological evaluation of 4-epi-7-dehydroxy-14,16-didemethyl-(+)-discodermolides as microtubule-stabilizing agents.简化的盘状海绵内酯类似物:4-表-7-脱羟基-14,16-二去甲基-(+)-盘状海绵内酯作为微管稳定剂的合成与生物学评价
J Med Chem. 2003 Jul 3;46(14):2846-64. doi: 10.1021/jm0204136.
10
Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.软海绵素,一种细胞毒性海洋药物,其稳定微管的能力比紫杉醇更强。
Biochemistry. 1996 Jan 9;35(1):243-50. doi: 10.1021/bi9515127.

引用本文的文献

1
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment.微管干扰药物:在卵巢上皮癌治疗中的现状与未来作用
Cancers (Basel). 2021 Dec 12;13(24):6239. doi: 10.3390/cancers13246239.
2
Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic.非天然 verticilide 对映异构体抑制 2 型 Ryanodine 受体介导的钙泄漏,具有抗心律失常作用。
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):4810-4815. doi: 10.1073/pnas.1816685116. Epub 2019 Feb 21.
3
Synthesis of (+)-discodermolide by catalytic stereoselective borylation reactions.
通过催化立体选择性硼氢化反应合成(+)-盘状海绵醇
Angew Chem Int Ed Engl. 2014 Sep 1;53(36):9632-6. doi: 10.1002/anie.201405455. Epub 2014 Jul 15.
4
Design and synthesis of (+)-discodermolide-paclitaxel hybrids leading to enhanced biological activity.设计并合成 (+)-discodermolide-紫杉醇杂合体,提高生物活性。
J Med Chem. 2011 Sep 22;54(18):6319-27. doi: 10.1021/jm200692n. Epub 2011 Aug 26.
5
(+)-Discodermolide: Total Synthesis, Construction of Novel Analogues, and Biological Evaluation.(+)-软海绵素:全合成、新型类似物的构建及生物学评价。
Tetrahedron. 2007 Jan 7;64(2):261-298. doi: 10.1016/j.tet.2007.10.039.
6
Drug development from marine natural products.源自海洋天然产物的药物研发。
Nat Rev Drug Discov. 2009 Jan;8(1):69-85. doi: 10.1038/nrd2487. Epub 2008 Dec 19.